These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7029018)

  • 1. Drug prophylaxis for arterial thromboembolism--1981.
    Wessler S
    JAMA; 1981 Nov; 246(21):2484-7. PubMed ID: 7029018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
    Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are agents affecting platelet functions clinically useful?
    Verstraete M
    Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
    [No Abstract]   [Full Text] [Related]  

  • 5. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
    Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
    Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation therapy in children with mechanical prosthetic cardiac valves.
    Bradley LM; Midgley FM; Watson DC; Getson PR; Scott LP
    Am J Cardiol; 1985 Sep; 56(8):533-5. PubMed ID: 4036839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
    Kutner M; Nixon G; Silverstone F
    Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
    Chesebro JH; Fuster V; Elveback LR; McGoon DC; Pluth JR; Puga FJ; Wallace RB; Danielson GK; Orszulak TA; Piehler JM; Schaff HV
    Am J Cardiol; 1983 May; 51(9):1537-41. PubMed ID: 6342354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin and warfarin therapy after acute myocardial infarction.
    Yedinak KC; Sproat TT
    Clin Pharm; 1993 Mar; 12(3):197-215. PubMed ID: 8491077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anticoagulants. Therapy and prophylaxis for thromboembolic phenomena.
    Quick D; Trowbridge AA
    Postgrad Med; 1984 Dec; 76(8):151-4, 156, 158-62. PubMed ID: 6504795
    [No Abstract]   [Full Text] [Related]  

  • 12. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.
    Stroke Prevention in Atrial Fibrillation Study Group Investigators
    N Engl J Med; 1990 Mar; 322(12):863-8. PubMed ID: 2407959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin and aspirin as thromboprophylaxis in atrial fibrillation.
    Lip GY; Lowe GD
    Br J Clin Pharmacol; 1996 May; 41(5):369-79. PubMed ID: 8735677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in venous thromboembolism by agents affecting platelet function.
    Salzman EW; Harris WH; DeSanctis RW
    N Engl J Med; 1971 Jun; 284(23):1287-92. PubMed ID: 5576438
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary and secondary prevention of arterial thromboembolism.
    Verstraete M
    Br Med Bull; 1994 Oct; 50(4):946-65. PubMed ID: 7804741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antithrombotic treatment for atrial fibrillation.
    Nademanee K; Kosar EM
    Am J Cardiol; 1998 Oct; 82(8A):37N-42N. PubMed ID: 9809899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin in chronic atrial fibrillation.
    Ramsay LE
    Lancet; 1993 May; 341(8857):1376-7. PubMed ID: 8098794
    [No Abstract]   [Full Text] [Related]  

  • 19. Stroke and bleeding in atrial fibrillation with chronic kidney disease.
    Olesen JB; Lip GY; Kamper AL; Hommel K; Køber L; Lane DA; Lindhardsen J; Gislason GH; Torp-Pedersen C
    N Engl J Med; 2012 Aug; 367(7):625-35. PubMed ID: 22894575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.